While newer antiretrovirals do not appear to cause lipoatrophy, the disfiguring side effect characterised by loss of fat from the face and limbs, the problem is still very much with us. David Menadue examins the latest research and treatments.

The annual conference of the Australasian Society for HIV Medicine (ASHM) was held in Melbourne in November. This article summarises some key developments.

A Treataware fact sheet on Lipoatrophy – the loss or ‘wasting’ of fat from the face, as well as sometimes the buttocks, upper arms legs or thighs. Options for prevention, treatment and management of fat loss associated with HIV treatments.

p(standfirst). It’s been three years in the making, but an Australian trial of polylactic acid for the treatment of facial wasting is about to get underway at last. But while the news is good, there are some important limitations to this project. KIRSTY MACHON reports.

The annual Retrovirus Conference is a key event on the HIV scientific calendar, and regularly highlights the most exciting ‘bleeding edge’ developments from the world of HIV science.

!(thumbnail)/files/2003-6-06_ashm-thumb.jpg( )! The annual conference of the Australasian Society for HIV Medicine (ASHM) is Australia’s only regular HIV medical conference. PAUL KIDD reports on the latest medical developments discussed at this year’s conference in Cairns.

Representations of positive people in the media. By Sean Slavin.

A report from the 8th European Conference on the Clinical Aspects and Treatment of HIV Infection, held in Athens, Greece in October, 2001.

A report from the 3rd International Workshop on Adverse Drug Reactions & Lipodystrophy, held in HIV in Athens, Greece from 23-26 October, 2001.